Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Imaging Behav ; 7(4): 511-23, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23835929

RESUMO

To examine relationships following adjuvant chemotherapy between circulating pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints in early stage breast cancer patients. 33 breast cancer patients who had completed initial treatment (surgery, ± radiation, 23 chemotherapy, 10 no chemotherapy) obtained resting (18)F-FDG PET/CT brain imaging at baseline and 1 year later. Pro-inflammatory cytokine markers (IL-1ra, sTNF-RII, CRP, and IL-6) and cognitive complaints were also assessed at both time points. At baseline, consistent correlations were seen between the left medial frontal and right inferior lateral anterior temporal cortices and inflammatory markers within the chemotherapy group, and not in the no chemotherapy group. After 1 year, correlations persisted in the medial frontal cortex and the temporal cortex, the latter shifting superiorly. Both of these regional correlations demonstrated the highest levels of significance when looking across the 1 year time frame (IL-1ra: peak voxel p < 0.0005; cluster size p < 0.0005, p = 0.001 after correction (medial prefrontal), p < 0.0005; cluster size p = 0.001, p = 0.029 corr. (anterior temporal), sTNF-RII: p < 0.0005; cluster size p = 0.001, p = 0.040 corr. (medial prefrontal)). Positive correlations were also seen within the chemotherapy group between baseline memory complaints and the medial frontal (p < 0.0005; cluster size p < 0.0005, p < 0.0005 corr.) and anterior temporal (p < 0.0005; cluster size p < 0.0005, p = 0.002 corr.) cortices at baseline and 1 year later. Metabolism in the medial prefrontal cortex and anterior temporal cortex was found to correlate with both memory complaints and cytokine marker levels in chemotherapy patients.


Assuntos
Antineoplásicos/efeitos adversos , Encéfalo/metabolismo , Neoplasias da Mama/tratamento farmacológico , Transtornos Cognitivos/induzido quimicamente , Transtornos Cognitivos/metabolismo , Citocinas/metabolismo , Mediadores da Inflamação/metabolismo , Adulto , Idoso , Biomarcadores/metabolismo , Encéfalo/efeitos dos fármacos , Neoplasias da Mama/complicações , Neoplasias da Mama/metabolismo , Quimioterapia Adjuvante/efeitos adversos , Cognição/efeitos dos fármacos , Feminino , Humanos , Pessoa de Meia-Idade , Distribuição Tecidual , Resultado do Tratamento
2.
Biophys J ; 63(6): 1462-70, 1992 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1489906

RESUMO

Structural properties of rabbit skeletal myosin head (S1) and the influence of the DTNB light chain (LC2) on the size and shape of myosin heads in solution were investigated by small angle x-ray scattering. The LC2 deficient myosin head, S1 (-LC2), and the S1 containing LC2 light chain, S1 (+LC2) were studied in parallel. The respective values of the radius of gyration were found to be (40.2 +/- 0.5) A and (46.7 +/- 1) A, while the maximum dimension was (190 +/- 15) A for both species. The large difference between the two Rg values suggest that LC2 is located close to one extremity of the myosin head, in agreement with most electron microscopy observations. All models derived from the x-ray scattering pattern of the native myosin head share a common overall morphology, showing two main regions, an asymmetric globular portion which tapers smoothly into a thinner domain of roughly equivalent length making an angle of approximately 60 degrees, with a contour length of approximately 210 A.


Assuntos
Subfragmentos de Miosina/química , Miosinas/química , Animais , Fenômenos Biofísicos , Biofísica , Técnicas In Vitro , Modelos Moleculares , Estrutura Molecular , Subfragmentos de Miosina/ultraestrutura , Miosinas/ultraestrutura , Conformação Proteica , Coelhos , Espalhamento de Radiação , Soluções , Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...